Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The genomic research field has been trending towards more data points, so the emergence of low-coverage sequencing.
Q&A: Riki Peters, PhD, MPH, on what this large genome-wide association study means for patients and the public
Researchers studied older women with breast cancer to discover why some people are particularly susceptible to “chemo brain.”
As mutations occur, a cell may gain the ability to grow without restraint and invade nearby tissue— to become, in effect, a cancer cell.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
Fast facts, common myths and misconceptions
Forty-five years since its launch, SEER can become an invaluable resource for performing and informing clinical and even basic research.
The study focused on children with a form of acute myeloid leukemia (AML), and the findings could also be relevant to other blood disorders.
Scientists aim to gather knowledge that improves future immunotherapies.
Cancer cells can be retrieved during such autopsies and kept alive, allowing researchers to experiment with ways to treat — or kill — them...
Cancer-contributing genes make brain tumors more aggressive and radiation-resistant.
The test, by 23andMe, analyzes DNA to help detect an increased risk of developing breast, ovarian or prostate cancers.
Researchers seek to better understand lung cancer in order to improve patients outcomes, especially in minority populations.
“It’s important to be positive and turn challenges into opportunities—and celebrate when those opportunities become scientific achievements”
A new study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.